Le Lézard
Classified in: Health, Science and technology

H5N8 'Bird Flu' Pandemic, Now Disruptive in South Africa, Might Have Been Controlled by Specific Replikins Vaccines and Blockers, Available Since 2013



BOSTON, Nov. 10, 2017 /PRNewswire/ -- Replikins, Ltd.'s Dr. Samuel Bogoch spoke this week on the H5N8 current pandemic  'bird flu' H5N8 at the 3rd annual Chernack Conference at Boston University School of Medicine on Crisis & Emergency Management. He noted that at least two million chickens have been lost to date in the current H5N8 outbreak in South Africa, creating economic havoc.

The Figure illustrates the advance warning of the current H5N8 outbreaks. Each 'plateau' of Replikin Counts in the Figure shows that the molecular evolution of H5N8 since 1983 had abundant mutations in 2013, 2014, and 2015 in the specific gene Replikin structures producing new strains preceding the outbreak in South Africa.

These conserved and new Replikins could have been used over the past four years to synthesize and test potentially preventive vaccines and blockers as done successfully for H5N1 (Avian Diseases: December 2009, Vol. 53, No. 4, pp. 613-617).

H5N8 has not yet created a pandemic in humans, as have three of its close lethal flu relatives: H1N1, H2N2, and H3N2. H1N1 produced two pandemics, in 1918 and 2009, causing millions of deaths in humans. Another close relative, H5N1, has passed to humans and killed 82% of individuals it infected in Indonesia, but like H5N8, has not as yet produced a pandemic in humans. 

The current influenza pandemic H5N8 has produced loss of lives in chickens and economic chaos in South Africa.

But when the next influenza or other virus pandemic occurs, and this one in humans, will we again have ignored the consistent specific evidence that it was coming obtained with Replikins Surveillance over the past decade of which virus was building for the attack?

With over 3 million Replikins automated analyses of 18 virus genes, one to four years advance notice of the outbreaks consistently provided time for both public health preparations and the synthesis and testing of blockers and vaccines.  The Gates Foundation and the World Bank have recently urged more efforts and new efforts in advance of the outbreak.

For the now-weekly Replikins SurveillanceTM Service for individual viruses, in animals and humans, contact:

Sam Bogoch, 184639@email4pr.com,  Tel 646-320-5910

SOURCE Replikins, Ltd.


These press releases may also interest you

at 03:00
FORT LAUDERDALE, Fla., Feb. 25, 2018 /PRNewswire-PRWeb/ -- In the midst of rising healthcare costs, Sabal Insurance Group continues to develop efficient employee benefits plans for its clients. While ensuring compliance with the Affordable Healthcare...

24 fév 2018
Experts in pediatric heart disease from multiple centers worldwide are sharing their findings at a large national conference sponsored by the Cardiac Center at Children's Hospital of Philadelphia (CHOP). Cardiology 2018, the 21th Annual Update on...

24 fév 2018
Terumo BCT announced today that it will be the exclusive distributor for Stafa Cellular Therapy (StafaCT), a U.S.-based software developer. StafaCT software supports healthcare facilities and cell labs as they manage each phase of the cellular...

24 fév 2018
JUUL Labs, Inc. today announced results from a preliminary study on the temperature regulation and harmful and potentially harmful constituents (HPHCs) of JUUL's Virginia Tobacco 5% nicotine-e-liquid filled pod. The findings, "Characterization of...

24 fév 2018
A new study reveals that most adults hold beliefs about the harms from nicotine that are opposite from what scientists have concluded. The findings, presented at the Society for Research on Nicotine and Tobacco 24th Annual Meeting in Baltimore,...

24 fév 2018
Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, announces that it has filed a class action against MiMedx Group, Inc. ("MiMedx" or the "Company") and certain of its officers for violations of...




News published on 10 november 2017 at 15:54 and distributed by: